MICRO-hospitals market is Gaining Major Traction with the launch of portable hospital for COVID-19 patients by an Indian startup Modulus Housing at IIT Madras University

 Micro-hospitals are hospitals designed both functionally and technically to provide the appropriate medical care in the most suitable place at the most affordable price. Health care services range from urgent medical assistance, acute surgical, elective surgery, long-term care, hospital care, home health care, extended care, specialty services, rehabilitation, social care, and community health care depending on market demand. Furthermore, these establishments offer specialty doctor opportunities for specialized services like cardiology, ear, nose, throat, and colostomy surgery; cardiopulmonary resuscitation (CPR), and intensive care medicine. The services offered by these facilities also cover rehabilitation services, skilled nursing facilities, and pediatric services. Healthcare facility design changes have played an important role in the way in which hospital facilities management addresses the issue of security. High tech emergency lights and emergency lighting has become a necessity in any modern hospital.

Micro-hospitals Market

Low initial investment and better accessibility to healthcare facilities are expected to drive growth of the global micro-hospitals market during the forecast period. Micro-hospitals are gaining major traction due to the fact that it requires a low initial investment. These hospitals aim to bridge the gap between the ambulatory centers and free-standing emergency rooms as they are unable to provide adequate service. Besides, micro-hospitals require lesser time for construction as compared to large-scale hospitals. These hospitals primarily provide patient-centric care, convenience, and easier accessibility to healthcare facilities. Moreover, the number of patients in these hospitals are fairly low. Thus, these factors are expected to drive growth of the global micro-hospitals market during the forecast period. Moreover, declining admission rates of large-scale hospitals are expected to boost the global micro-hospitals market growth over the forecast period.

However, the lack of adequate and advanced facilities required for particular surgeries is expected to hinder the global micro-hospitals market growth over the forecast period. Among regions, North America is expected to witness significant growth in the global micro-hospitals market during the forecast period. This is owing to per capita expenditure on healthcare across the region. According to the Centers for Disease Control and Prevention (CDC), around 90% of people in the U.S. have insurance coverage and are potential users of micro-hospitals.

Major competitors involved in the global micro-hospitals market are Emerus Hospitals, Christus Health, Baylor Scott & White Saint Luke’s Health System, Dignity Health, and SCL Health.

For instance, in August 2020, Modulus Housing, an Indian start-up incubated at a public technical and research university named IIT Madras, developed a portable hospital unit for COVID-19 patients.

Global Liquid-immersed Transformers Market is Expanding Rapidly with Hitachi ABB Power Grids launching open and scalable TXpertTM Ecosystem for digitalization of transformers

 

Transformers is an exciting product in the modern world. A full range of electrical and power distribution transformers suitable to almost all industrial, commercial and domestic applications. They provide the basic convenience and safety of standard transformers, but with added flexibility and safety. These flexible units allow for a number of applications and can be tailor-made to give maximum performance and safety. They are available in both open and liquid-immersed configurations and can be tailored to offer maximum efficiency and reliability, whilst reducing costs and waste. Transformers fitted into most domestic power distribution lines are typically available in two types namely open or enclosed transformer design.  

Liquid-immersed Transformers

 

Increasing consumption of electricity is expected to drive growth of the global liquid-immersed transformers market. Electricity consumption has increased in both developed and emerging economies over the years. According to the World Bank, electric power consumption in India reached 804.514 kWh per capita in 2014, increasing from 640.395 kWh per capita in 2010. According to the Our World in Data, in 2019, Asia Pacific consumed 71,544 TWh of energy. As a result of this, the demand for transformers, especially liquid-immersed transformers has increased significantly. Liquid-immersed transformers are more efficient and smaller than conventional transformers are suitable for indoor use due to low operating noise. Hence, such factors are expected to drive growth of the global liquid-immersed transformers market. Furthermore, rising energy-generating capacities of renewable sources are expected to propel the global liquid-immersed transformers market growth in the near future.

However, challenges associated with fire prevention due to the use of cooling-liquid medium may catch fire it is not protected adequately. Thus, these factors are expected to restrain growth of the global liquid-immersed transformers market. Among regions, Asia Pacific is expected to witness significant growth in the global liquid-immersed transformers market. This is owing to large scale requirements and the presence of the largest consumer base. Furthermore, North America is expected to register a robust growth rate, owing to increasing demand from various industries in the region.

Key companies involved in the global liquid-immersed transformers market are ABB, Siemens AG, CG, Schneider Electric, General Electric, China XD Group EREMU, CNC Group, Dandong Xintai Electric, and Elsewedy Electric.

For instance, in September 2020, Hitachi ABB Power Grids, a Switzerland-based company, launched the open and scalable TXpertTM Ecosystem for the digitalization of transformers.

Rise in the number of surgeries around the globe is escalating the growth of the intraoperative imaging market

 Intraoperative imaging is a medical term used to describe an imaging procedure used to view the internal organs of a patient. Typically, intraoperative imaging is used in the operating room to view internal organs before, during, and after surgery. Intraoperative imaging has expanded to include all parts of the body. It is now used for all ages and can be used in medicine for the prevention or detection of diseases and injuries that may have affected internal organs. Intraoperative imaging is used for many reasons in medicine. Some intraoperative imaging modalities allow the physician to know if a patient is improving before, during, and after surgery, and thus the potential for early recovery is greater.

The growing incidence of surgeries coupled with the growing advancement in technology is fueling the growth of the intraoperative imaging market. According to the International Society of Aesthetic Plastic Surgery (ISAPS), there is a 7.4% increase in cosmetic procedures completed in 2019. The 7.4% increase is higher than in 2018 (5.6%). Both surgical and nonsurgical procedures increase in 2019 (7.1% and 7.6% respectively) compared to an increase only in nonsurgical procedures in 2018. The rising prevalence of chronic disease and increasing geriatric population which is creating advanced healthcare needs is again propelling the growth of the market. 

intraoperative imaging market

 

North America is projected to gain significant growth over the forecast period and this is attributed to the high burden of chronic disease in the region due to the increasing geriatric population. According to the Rural Health Information Hub, the U.S. population is aging. At present, there are more than 46 million older adults age 65 and older living in the U.S.; by 2050, that number is expected to grow to almost 90 million. Between 2020 and 2030 alone, the time the last of the baby boom cohorts reach age 65, the number of older adults is projected to increase by almost 18 million. Moreover, the rapid adoption of advanced medical technologies is again augmenting the growth of the market.

Key Developments:

  1. In September 2019, Brainlab, the digital medical technology company has launched Loop-X™, the first mobile intraoperative imaging robot at NASS 2019 in Chicago. The Loop-X robotic architecture has a new standard in flexibility, which offer additional degrees of freedom to any surgical procedure

  2. In October 2017, IMRIS, the global provider of intraoperative imaging has launched its new corporate brand identity and its comprehensive consulting services approach during the 2017 Congress of Neurological Surgeons (CNS) Annual Meeting

  3. In September 2019, EchoPixel launched Intraoperative Device which can be used in complex and life-saving surgeries. The new device provides an interactive 3D holographic experience that physicians can use in the operating room or cath lab

Gouty Arthritis Market is Gaining Significant Traction with ROMEG Therapeutics receiving the U.S. FDA approval for its GLOPERBA (colchicine) Oral Solution, 0.6 mg/5 mL for prophylaxis of gout flares in adults

 

Gouty arthritis is a type of arthritis that causes inflammation, typically in one joint, which begins suddenly. Gouty arthritis is caused by the deposition of needle-shaped crystals of uric acid in a joint. The primary symptoms of gouty arthritis include severe pain, swelling, and redness in joints, often in the big toe. 

 

Gouty Arthritis Market

Increasing prevalence of gout with rising alcohol consumption is expected to drive growth of the global gouty arthritis market. According to the Centers for Disease Control and Prevention (CDC), from 2013-2015 around 54.4 million adults in the U.S. have some form of arthritis, gout, rheumatoid arthritis, or fibromyalgia. According to the Arthritis Foundation, 8 million people in the U.S. suffer from gout arthritis every year. According to the same source, high intake of sugary or alcoholic drinks is one of the major risk factors for gout arthritis. Alcohol is a major source of purine, which produces uric acid. High levels of uric acids in the body can result in the formation of crystals of uric acid, eventually leading to gout. Hence, such factors are expected to drugs market is expected to drive growth of the global gouty arthritis market. Furthermore, increasing adoption of biologics and increasing R&D activities in regenerative medicines is expected to propel the global gouty arthritis market growth in the near future. 

 Side-effects associated with therapeutics drugs and high indirect costs of gout therapeutics are expected to hamper the global gouty arthritis market growth in the near future. Besides, lack of awareness among the medical fraternity regarding effective treatment of the condition, typically in emerging economies is expected to restrain growth of the market. Among regions, North America is expected to witness significant growth in the global gouty arthritis market. This is owing to high prevalence of gouty arthritis in the U.S. According to the clinical guidelines for gout published in Annals of Internal Medicine, in 2017, around 3.9% of U.S. adults aged 20 years and above reported gout at least once in a lifetime. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to rising number of patients suffering from chronic diseases such as cardiovascular disease across the region.

Key companies involved in the global gouty arthritis market are Lannett Company, Inc., Teijin Pharma Ltd, Boehringer Ingelheim, Takeda Pharmaceutical Company Ltd, GlaxoSmithKline plc, ROMEG Therapeutics, LLC, Horizon Therapeutics plc, Regeneron Pharmaceuticals, Mylan NV, Merck& Co. Inc., and Novartis International AG.

For instance, in February 2019, ROMEG Therapeutics, LLC received the U.S. Food and Drug Administration (FDA) approval for its GLOPERBA (colchicine) Oral Solution, 0.6 mg/5 mL for prophylaxis of gout flares in adults.

The Global Diabetes Injection Pens Market Continues To Grow Owing To the Increasing Rate of Type 1 Diabetes across the World and Type 2 Diabetes in the Pediatric Population Mainly In Developed Nations

 

Diabetes injection pens are now more commonly used to administer oral diabetes medications to people who have difficulty swallowing. These pens allow the diabetics to inject themselves with a dose of their chosen oral diabetes medication. Insulin pumps and vial style pumps are often used for administering insulin shots and there are also single-dose vials that can be stored in a personal bag or small box and taken at a convenient time.

There are many different types of diabetes injection pens available from medical supply companies offering an array of options to the consumer. These are made of rubber latex or similar flexible material that is durable and resistant to infection. The needles are usually made of sterile stainless steel but rubber inserts are available for use with some units. Depending on what brand and type of diabetes medicine are being ordered, the pen will be embossed with the letter of the patient's first name, the word "diabetic" or another symbol indicating this fact and their personal information.

Diabetes injection pens Market

 

Market Dynamics

The main factor driving the growth of the diabetes injection pens market is the rapid increase of diabetes across the globe. For instance, according to a 2020 report by CDC approximately 34.2 million people were suffering from diabetes. The new cases of diabetes are high among non-Hispanic blacks than non-Hispanic whites and non-Hispanic Asians. Other factors such as injuries caused due to needle sticks and bacterial infections caused by regular usages of syringes are estimated to propel the market growth of the insulin injection pens market.

However, the abundance of insulin patches, and other safer substitute for insulin injection pens are the main restraining factors hindering the growth of the market.

This market is distributed in five regions that include North America, Europe, Asia-Pacific, Middle East, and Africa, and Latin America. Among these North America is estimated to hold a significant share of the diabetes injection pens market owing to the increasing rate of type-1 diabetes and the development of new, safer to use pens by key players in the region. For instance, according to the Americans with Disabilities Act (ADA), in 2018, approximately 1.25 million people were suffering from type 1 diabetes. ADA estimates that around 40,000 people get diagnosed with Type 1 diabetes every year. The diabetes injection pens market in the Asia Pacific is estimated to witness significant growth owing to the rising concerns among the patients and the development and expansion of healthcare sectors.

Competitive Analysis

Key players operating in the global diabetes injection pens market include Jiangsu Delfu Co., Dickinson and Company, Becton, Eli Lilly and Company, Biocon Ltd, AstraZeneca Plc, and Novo Nordisk A/S.

Increasing Focus on Aesthetic Appeal and Increasing Expenditure on Personal Care Products to Augment Growth of Copper Sulfate Market

 

Copper sulfate is found in personal care products. It is also used as a fungicide and herbicide for the treatment of orchards and vineyards and in industrial production of Rayon.

Market Dynamics

Increasing focus on aesthetic appeal is expected to propel growth of the copper sulfate market. For instance, according to a 2018 survey by GlobalData, around three quarters of South Korean men undertake a beauty or grooming treatment at least once a week. Moreover, increasing expenditure on personal care products is also expected to aid in growth of the market. For instance, according to the U.S. Bureau of Labor Statistics, average annual expenditure on personal care products in the U.S. increased from US$ 707 in 2016 to US$ 768 in 2018. 

Copper Sulfate

 

Increasing demand for food is expected to boost demand for fungicide and herbicide, thereby offering lucrative growth opportunities for players in the copper sulfate market. For instance, according to Food and Agriculture Organization, worldwide food demand is expected to increase by 70% by 2050. Moreover, increasing demand for Rayon fabrics and growth in the textile sector is also expected to aid in growth of the market. For instance, according to National Council of Textile Organizations (NCTO), 2018 state of the U.S. Textile Industry Address, in 2017, the value of U.S. man-made fiber and filament, textile, and apparel shipments totaled an estimated US$ 77.9 billion, an increase from US$ 74.4 billion in output in 2016 and an increase of 16% since 2009.

However, significant drop in wine production worldwide is expected to limit demand for copper sulfate in orchards and vineyards. This in turn is expected to hinder growth of the copper sulfate market. For instance, according to the International Organization of Vine and Wine, the world’s total wine production in 2019 was estimated to be 263 million hectoliters, a drop of 10% compared to 2018.

Competitive Analysis

Major players operating in the copper sulfate market include, Atotech, Allan Chemical Corporation, WEGO Chemical & Mineral Corp., and NOAH Technologies Corporation.

Major players operating in the copper sulfate market are focused on adopting various marketing strategies to enhance their market share. For instance, in 2020, Wego Chemical Group announced to present at the American Coatings Show 2020. Similarly, in 2019, Atotech announced to present at the 2019 International Electronics Circuit Exhibition in Shenzhen, China.

In-depth report on Copper Sulfate Market by Coherent Market Insights:

https://www.coherentmarketinsights.com/ongoing-insight/copper-sulfate-market-340



Increasing Aesthetic Appeal and Increasing Expenditure on Personal Care Products to Augment Growth of Nutricosmetics Market

 

Nutricosmetics refers to nutritional supplements that are used to enhance aesthetic appeal. Skin care usually includes the application of creams, lotions and other skin products. Nutricosmetics can be used to make skin look younger and healthier. The ingredients used to make these products usually include vitamins, antioxidants, and other nutrients that the skin needs to function properly. There are other forms that can be used in making the skin look younger. 

Nutricosmetics Market

 

Market Dynamics

Increasing aesthetic appeal is expected to propel growth of the nutricosmetics market. For instance, according to a 2018 survey by GlobalData, around three quarters of South Korean men undertake a beauty or grooming treatment at least once a week. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.

Increasing expenditure on personal care products is expected to offer lucrative growth opportunities for players in the nutricosmetics market. For instance, according to the U.S. Bureau of Labor Statistics, average annual expenditure on personal care products in the U.S. increased from US$ 707 in 2016 to US$ 768 in 2018. Moreover, significant growth in the e-commerce sector is also expected to aid in growth of the market. For instance, according to India Brand Equity Foundation, the e-commerce sector in India is expected to reach US$ 200 billion by 2026 from US$ 38.5 billion as of 2017.

The nutricosmetics market is witnessing increasing investment. For instance, in January 2020, Mr. Joël Palix, the founder of boutique consultancy Palix Unlimited, invested in Lashilé Beauty, a nutricosmetics company.

Competitive Analysis

Major players operating in the nutricosmetics market include, Frutarom Ltd., Lucas Meyer Cosmetics S.A.S., Sanofi-Aventis U.S. LLC, Croda International Plc, Pfizer Inc., Functionalab Inc., Laboratoires Inneov SNC., Beiersdorf Ag, BASF SE, Borba, Inc., Frutels LLC, ISOCELL SA, GlaxoSmithKline Pharmaceuticals Limited, ExcelVite, Denomega Nutritional Oils AS, Groupe Danone SA, IMCD Group BV, and Lonza Group Ltd.

Major players operating in the nutricosmetics market are focused on adopting M&A strategies to enhance their market share. For instance, in 2019, IFF, an innovator of scent, taste, and nutrition, and its affiliate, IFF-Lucas Meyer Cosmetics, completed the acquisition of Speximo AB, a Swedish technology company.

In-depth Report on Nutricosmetics Market by Coherent Market Insights:

https://www.coherentmarketinsights.com/market-insight/nutricosmetics-market-518



Global Bio-Based Propylene Glycol Market 2020 Industry Challenges Business Overview And Forecast Research Study 2026

The worldwide substance industry has been intensely reliant upon non-renewable energy source for delivering an assortment of pe...